Final Rules

• Ninety-Day Waiting Period Limitation

  

• Guidance for Industry Demonstration of the Quality Factor Requirements for Eligible Infant Formulas; Availability

  

• Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements

  

• Maximum Civil Money Penalty Amounts; Civil Money Penalty Complaints; Confirmation of Effective Date

  

• Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act

  

• Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions

  

• General and Plastic Surgery Devices: Reclassification of Ultraviolet Lamps for Tanning, Henceforth To Be Known as Sunlamp Products and Ultraviolet Lamps Intended for Use in Sunlamp Products

  

• Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis Complex in Respiratory Specimens

  

• Administrative Detention of Drugs Intended for Human or Animal Use

  

• Medicare Program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs

  

• Patient Protection and Affordable Care Act; Exchange and Insurance Market Standards for 2015 and Beyond

  

• Food Additives Permitted for Direct Addition to Food for Human Consumption; Advantame

  

• Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review, Technical Amendment

  

• Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Part II

  

• Prospective Payment System for Federally Qualified Health Centers; Changes to Contracting Policies for Rural Health Clinics; and Changes to Clinical Laboratory Improvement Amendments of 1988 Enforcement Actions for Proficiency Testing Referral

  

• Medicare Program; FY 2014 Hospice Wage Index and Payment Rate Update; Hospice Quality Reporting Requirements; and Updates on Payment Reform; Final Rule

  

• Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013; Final

  

• Final Priorities, Requirements, Definitions, and Selection Criteria; Race to the Top—Early Learning Challenge; Final Rule

  

• Patient Protection and Affordable Care Act; Program Integrity: Exchange, SHOP, and Eligibility Appeals; Final Rule

  

• Unique Device Identification System; Final Rule